Binqi Wang
Zhejiang Key Laboratory Of Research And Translation For Kidney Deficiency Stasis Turbidity Disease, P.R. China
Hangzhou, 310006, China
Hangzhou, 310006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Urinary Dickkopf-3 as a biomarker for kidney-function decline: a systematic review and meta-analysis.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 07, 2026
Letter to the Editor: Interpreting the Clinical Applicability of SGLT-2 Inhibitors in MASH-Related Cirrhosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 03, 2026
Do MASLD subtypes truly diverge in pregnancy risk, or do they reflect the same metabolic burden?
Journal: Hepatology international
Published: December 12, 2025
Hidden structure, visible effects: uneven genotype missingness and its implications for interpreting Peg-IFN efficacy in CHB trials.
Journal: Hepatology international
Published: December 12, 2025
Neutrophil Extracellular Traps in Diabetic Kidney Disease: Mechanisms of Pathogenesis and Emerging Therapeutic Strategies.
Journal: Drug design, development and therapy
Published: November 20, 2025
Qingxin Lianzi Yin Improves Chronic Kidney Disease by Targeting Ferroptosis via the TLR4/HIF-1α Pathway.
Journal: Mediators of inflammation
Published: November 19, 2025
Inpatient diabetes management in Europe: The limits of a single-day snapshot.
Journal: European journal of internal medicine
Published: November 13, 2025
On "The different colorectal tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use a network meta-analysis of 68 randomized controlled trials" - correspondence.
Journal: International journal of surgery (London, England)
Published: October 16, 2025
Germacrone suppresses renal cancer growth by regulating c-Fos-mediated lipid metabolism.
Journal: Lipids in health and disease
Published: October 09, 2025
PTPN22 Dephosphorylates CBL to Inhibit PD-L1 Ubiquitination and Drive Immunosuppression in Renal Cell Carcinoma.
Journal: International journal of biological sciences
Published: July 25, 2025
Lipophagy in immune cells and immune response modulation: Mechanisms and therapeutic potential.
Journal: International immunopharmacology
Published: May 08, 2025
Last Updated: 09/26/2026